Skip to main content
Signal8

Pamir Ozan

SEC insider (Form 3/4/5 filer). CIK 0001834681. Chief Financial Officer at Niagen Bioscience, Inc. (NAGE). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in LOS ANGELES, CA.

Companies Pamir Ozan has filed insider reports for

  • Niagen Bioscience, Inc. (NAGE): Officer, Chief Financial Officer
Pamir Ozan profile photo

Pamir Ozan

CIK: 0001834681

Transaction Breakdown

Open Market Buys (P)3 (42.9%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Niagen Bioscience, Inc. logo
NAGE

Niagen Bioscience, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Niagen Bioscience, Inc. logo
    NAGE

    Niagen Bioscience, Inc.

    Jun 30, 2026
    Award
    Direct
    4.3K shares at avg. $2.71$12K
  • Niagen Bioscience, Inc. logo
    NAGE

    Niagen Bioscience, Inc.

    Feb 19, 2026
    Award

    Employee Stock Options (right to buy)

    Direct
    62.1K shares-
  • Niagen Bioscience, Inc. logo
    NAGE

    Niagen Bioscience, Inc.

    Nov 14, 2025
    Purchase
    Indirect
    2.2K shares at avg. $6.85$15K
  • Niagen Bioscience, Inc. logo
    NAGE

    Niagen Bioscience, Inc.

    Nov 14, 2025
    Purchase
    Direct
    4.5K shares at avg. $6.81$30K
  • ChromaDex Corp. logo
    CDXC

    ChromaDex Corp.

    Feb 12, 2025
    Award

    Employee Stock Options (right to buy)

    Direct
    17.2K shares-
  • ChromaDex Corp. logo
    CDXC

    ChromaDex Corp.

    Nov 22, 2024
    Purchase
    Direct
    2.9K shares at avg. $7.36$21K
  • ChromaDex Corp. logo
    CDXC

    ChromaDex Corp.

    Oct 21, 2024
    Award

    Employee Stock Options (right to buy)

    Direct
    146.5K shares-

1-7 of 7